SCHEMBL27057602

SCHEMBL27057602

CC(=O)[C@H](Cc1ccccc1)NC(=O)CCCCCN1C(=O)C=CC1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 1/20 0.51
▸ HDAC4 P56524 1/20 0.51
▸ HDAC1 Q13547 1/20 0.51
▸ HDAC7 Q8WUI4 1/20 0.51
▸ HDAC2 Q92769 1/20 0.51
▸ HDAC10 Q969S8 1/20 0.51
▸ HDAC11 Q96DB2 1/20 0.51
▸ HDAC8 Q9BY41 1/20 0.51
▸ HDAC6 Q9UBN7 1/20 0.51
▸ HDAC9 Q9UKV0 1/20 0.51
▸ HDAC5 Q9UQL6 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.49
▸ GSK3A P49840 1/20 0.49
▸ GSK3B P49841 1/20 0.49
▸ FAAH O00519 2/20 0.48
▸ CTSG P08311 1/20 0.48
▸ CMA1 P23946 1/20 0.48
▸ PTGS1 P23219 4/20 0.48
▸ PTGS2 P35354 4/20 0.48
▸ AKT1 P31749 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29528481 0.91 FAAH (0.56) GSK3AGSK3BFAAHCTSGCMA1
SCHEMBL5550466 0.91 FAAH (0.56) GSK3AGSK3BFAAHCTSGCMA1
SCHEMBL5550460 0.91 FAAH (0.56) GSK3AGSK3BFAAHCTSGCMA1
SCHEMBL8263020 0.86 PARP1 (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL29114311 0.83 FAAH (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL29235949 0.83 FAAH (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL21320461 0.83 PTGS1 (0.56) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL20787950 0.82 FAAH (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL17003656 0.82 FAAH (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL22519634 0.82 AKT1 (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024018471-A1 CATHEPSIN INHIBITORS AND USE THEREOF IN A METHOD FOR DETECTING AND TREATING RESISTANCE TO IMMUNOTHERAPY YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-01-25 — — WO disclosed
Send feedback